Search for: "AstraZeneca Inc."
Results 181 - 200
of 340
Sort by Relevance
|
Sort by Date
24 Feb 2011, 1:49 pm
Astrazeneca Pharmaceuticals, 832 A.2d 1241, 1243 (Conn. [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US: Watson… [read post]
15 Feb 2011, 4:06 am
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
13 Feb 2011, 9:08 pm
Astrazeneca... [read post]
2 Feb 2011, 2:39 pm
Apotex, Inc. [read post]
31 Dec 2010, 3:57 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
31 Dec 2010, 2:46 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
22 Dec 2010, 3:01 am
Inc. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing… [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
23 Nov 2010, 2:00 pm
The largest fiscal year 2010 False Claims Act recoveries came from the pharmaceutical and medical device industries, which accounted for $1.6 billion in settlements, including the $669 million from Pfizer Inc., $302 million from AstraZeneca, and $192.7 from Novartis Pharmaceutical Corporation. [read post]
23 Nov 2010, 1:00 am
Apotex, Inc. [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
9 Nov 2010, 10:46 am
Abraxis Bioscience Inc. v. [read post]
9 Nov 2010, 4:30 am
Janssen Pharmaceutica, Inc., 04-C-3967, 27th Judicial Court, St. [read post]
4 Nov 2010, 10:59 am
Apotex, Inc. [read post]
4 Nov 2010, 6:14 am
” Golden Blount, Inc. v. [read post]
